TickerFacts.

A business in context

CPIX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K/A · Current report

    Report date 2026-04-21 · 0001087294-26-000068 · Items 5.07

  2. 8-K · Current report

    Report date 2026-08-28 · 0001087294-26-000064 · Items 7.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001087294-26-000062

  4. 8-K · Current report

    Report date 2026-08-04 · 0001087294-26-000058 · Items 2.02,9.01

  5. 8-K · Current report

    Report date 2026-07-13 · 0001087294-26-000055 · Items 8.01

  6. 8-K · Current report

    Report date 2026-06-29 · 0001104659-26-079871 · Items 1.01,1.02,2.01,5.02,8.01,9.01

  7. 8-K · Current report

    Report date 2026-06-24 · 0001087294-26-000053 · Items 5.07

  8. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001087294-26-000049

  9. 8-K · Current report

    Report date 2026-05-05 · 0001087294-26-000046 · Items 2.02,9.01

  10. 8-K · Current report

    Report date 2026-04-21 · 0001087294-26-000043 · Items 5.07

  11. 8-K · Current report

    Report date 2026-04-22 · 0001104659-26-047335 · Items 1.01,7.01,8.01,9.01

  12. 4 · Ownership change

    Report date 2026-03-18 · 0001632384-26-000002

  13. 4 · Ownership change

    Report date 2026-03-18 · 0001572342-26-000002

  14. 4 · Ownership change

    Report date 2026-03-18 · 0001087294-26-000040

  15. 4 · Ownership change

    Report date 2026-03-18 · 0001087294-26-000039

  16. 4 · Ownership change

    Report date 2026-03-18 · 0001087294-26-000037

  17. 4 · Ownership change

    Report date 2026-03-18 · 0001087294-26-000036

  18. 4 · Ownership change

    Report date 2026-03-18 · 0001087294-26-000035

  19. 4 · Ownership change

    Report date 2026-03-18 · 0001087294-26-000034

  20. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001087294-26-000025

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001087294-26-000020

  22. 8-K · Current report

    Report date 2026-03-03 · 0001087294-26-000015 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-02-04 · 0001087294-26-000011 · Items 8.01

  24. 8-K · Current report

    Report date 2025-11-18 · 0001087294-25-000023 · Items 1.01,2.03

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001087294-25-000020

  26. 8-K · Current report

    Report date 2025-11-04 · 0001087294-25-000017 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-10-21 · 0001087294-25-000012 · Items 8.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-039326

  29. 8-K · Current report

    Report date 2025-08-05 · 0001628280-25-037923 · Items 2.02,9.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-024342

  31. 8-K · Current report

    Report date 2025-05-06 · 0001628280-25-022753 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-04-28 · 0001628280-25-020222 · Items 5.07

  33. 8-K · Current report

    Report date 2025-03-19 · 0001628280-25-013875 · Items 8.01

  34. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001628280-25-011735

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-011366

  36. 8-K · Current report

    Report date 2025-03-04 · 0001628280-25-009967 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2025-02-19 · 0001628280-25-006430 · Items 8.01

  38. 8-K · Current report

    Report date 2025-02-14 · 0001628280-25-005744 · Items 8.01,9.01

  39. 8-K · Current report

    Report date 2025-02-04 · 0001628280-25-003753 · Items 8.01

  40. 8-K · Current report

    Report date 2024-12-09 · 0001628280-24-050499 · Items 8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001087294CUMBERLAND PHARMACEUTICALS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$37.87M$40.67M
    2023-12-31$39.55M$43.73M
    2022-12-31$42.01M$48.36M
    2021-12-31$35.05M$43.57M
    2020-12-31$35.84M$46.66M
    2019-12-31$32.41M$42.71M
    2018-12-31$28.80M$38.65M
    2017-12-31$40.38M$55.50M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗